Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Kevzara (sarilumab) has received a thumbs-up from the European Medicine Agency (EMA), which has recommended that the European Commission approve it to treat adults with moderate to severe rheumatoid arthritis, ... Read more
Rheumatoid arthritis patients who benefit from Rituxan (rituximab) have a distinctive drop in T-cells after treatment — a change that corresponds to an improvement in symptoms. The findings show that ... Read more
R-Pharm recently reported positive results from Phase 2 clinical trials of olokizumab for the treatment of rheumatoid arthritis, supporting the drug’s move into Phase 3 testing now underway. The data was ... Read more
The presence of certain autoantibodies in rheumatoid arthritis (RA) is linked to bone loss in patients with early disease, suggesting that bone remodeling in rheumatoid arthritis is directly connected to ... Read more
Smoking and obesity in patients with rheumatoid arthritis (RA) are factors preventing patients from reaching sustained remission, according to findings presented at the European League Against Rheumatism Annual Congress (EULAR ... Read more